ASHFORD HOSPITALITY TRUST ANNOUNCES CEO SUCCESSION PLAN
DALLAS, April 18, 2024 /PRNewswire/ -- Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") today announced that Rob Hays, the current President and Chief Executive Officer of Ashford Trust, will be stepping down effective June 30,...
Bone Health and Osteoporosis Foundation Announces Call for Nominees for New Robert F. Gagel, M.D. Community Leadership Award
ARLINGTON, Va., April 19, 2024 /PRNewswire/ -- The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals...
Quarterra Multifamily Announces the Continued Growth of its Emblem Communities Development Program
Program designed to deliver attainable options for middle-income renters has delivered 7 communities, with 2 more under construction
CHARLOTTE, N.C., March 27, 2024 /PRNewswire/ -- Quarterra Multifamily, a subsidiary of Lennar Corporation and a vertically integrated multifamily apartment builder, developer and property...
CAPA Airline Leader Summit Americas Open for Media Registration
SYDNEY, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Complimentary media passes are now available for the CAPA Airline Leader Summit Americas on May 9th and 10th in...
Salboy Launches Obsidian – 10th Property Development in Manchester City Centre USA – English Middle East – English APAC – English APAC – Traditional Chinese Middle East – Arabic
MANCHESTER, England, April 19, 2024 /PRNewswire/ -- After the successful launch of W Residences, Manchester, the first branded residences in The City, British property developer Salboy announces the launch of Obsidian. The scheme marks the tenth luxury residential scheme in the...
Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old
In the United States, the Osia System is now cleared for children ages 5 and older
The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness...